Offer Andrew 4
4 · Sight Sciences, Inc. · Filed Jul 19, 2021
Insider Transaction Report
Form 4
Offer Andrew
Director
Transactions
- Conversion
Common Stock
2021-07-19+3,162→ 3,162 total - Conversion
Series C Preferred Stock
2021-07-19−1,581→ 0 total→ Common Stock (3,162 underlying) - Conversion
Common Stock
2021-07-19+2,225,752→ 2,355,062 total(indirect: See footnote) - Conversion
Series B Redeemable Convertible Preferred Stock
2021-07-19−25,920→ 0 total(indirect: See footnote)→ Common Stock (51,840 underlying) - Conversion
Series A Redeemable Convertible Preferred Stock
2021-07-19−1,086,956→ 0 total(indirect: See footnote)→ Common Stock (2,173,912 underlying)
Footnotes (2)
- [F1]The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.
- [F2]These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.